Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Feb 15, 2024; 16(2): 493-513
Published online Feb 15, 2024. doi: 10.4251/wjgo.v16.i2.493
Published online Feb 15, 2024. doi: 10.4251/wjgo.v16.i2.493
Figure 11 Target validation of resveratrol in gastric cancer.
A: Reverse transcription quantitative PCR (RT-qPCR) detection of FBJ murine osteosarcoma viral oncogene homolog expression levels. B: RT-qPCR detection of Matrix metallopeptidase 9 expression levels. aP < 0.05; bP < 0.01; cP < 0.001, dP < 0.0001. NS: No significance. FOS: FBJ murine osteosarcoma viral oncogene homolog; MMP9: Matrix metallopeptidase 9.
- Citation: Ma YQ, Zhang M, Sun ZH, Tang HY, Wang Y, Liu JX, Zhang ZX, Wang C. Identification of anti-gastric cancer effects and molecular mechanisms of resveratrol: From network pharmacology and bioinformatics to experimental validation. World J Gastrointest Oncol 2024; 16(2): 493-513
- URL: https://www.wjgnet.com/1948-5204/full/v16/i2/493.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i2.493